Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Background The clinical benefits of high-dose intravenous immunoglobulin (IVIg) in treating
COVID-19 remained controversial. Methods We systematically searched databases up to …

Intravenous immunoglobulin (IVIg) therapy has been suggested as a potential treatment
option for hospitalised COVID‐19 patients. The aim of this systematic review and meta …

Objectives Severe-to-critical COVID-19 has been associated with exaggerated immune
responses, and anti-inflammatory agents including corticosteroid and interleukin-6 …

Background The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19
remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG …

Objectives At the present time, there is an absence of any proven effective antiviral therapy
for patients with coronavirus disease 2019 (COVID-19). The aim of this study was to assess …

Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …

Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …

The COVID-19 pandemic is one of the greatest infectious challenges in recent history.
Presently, few treatment options exist and the availability of effective vaccines is at least one …

Background The effective treatment of coronavirus disease 2019 (COVID-19) remains
unclear. We reported successful use of high-dose intravenous immunoglobulin (IVIg) in …